Pancreatic Cancer Research

ResearcherNankai UniversityNo recent work listed

Chenggang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5551-6093; OpenAlex author ID A5019413944. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00432-022-04542-9↗
  2. ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1. First author DOI 10.1038/s41389-022-00418-2↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yin Li · 1 shared paper, 2023 · strength 0.22
  2. Juan Yang · 1 shared paper, 2023 · strength 0.22
  3. Shenming Li · 1 shared paper, 2022 · strength 0.15
  4. Xingmao Zhang · 1 shared paper, 2022 · strength 0.15
  5. Hua Fan · 1 shared paper, 2022 · strength 0.15
  6. Zhuo Shao · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.